Delivery Order SPE2DB24D2101-SPE2DB25FKHKW

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Colestipol HCl 1 GM tablets. The contract is a Delivery Order valued at $7,352.07 with a firm fixed price, and has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,110.21 award is for the delivery of Colestipol HCL 1 GM Tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,351.68, is for the supply of Colestipol HCl 1 GM Tablets in quantities of 120 per bottle. The contract is a firm fixed-price delivery order with an ultimate completion date of June 28, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,348.33 firm fixed price contract is for the delivery of 4,564,286,736 colestipol hydrochloride 1 gram tablets. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, to provide a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $1,321.02 and runs through January 29, 2025. It is not designated as a set-aside contract. The award is for the delivery of COLESTIPOL HCL 1 GM TABLET 120S, a pharmaceutical product, to support military and federal healthcare programs. AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,462.98 contract is for the delivery of 120 count tablets of Colestipol HCl 1 GM, a medication used to treat high cholesterol. The contract has a completion date of May 9, 2023 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...
This federal contract award, valued at $3,221.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of Colestipol Hydrochloride 1 gram tablets, a medication used to manage high cholesterol levels. The contract has an ultimate completion date of March 3, 2025 and uses a Firm Fixed Price pricing structure. AmerisourceBergen holds a...
This is a $2,342.65 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4560912946 Colestipol HCL 1 GM Tablet 120S, a cardiovascular medication, with a performance period ending on May 12, 2023. This contract is a task order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division for the provision of 4,564,840,868 units of Colestipol Hydrochloride 1 gram tablets. The delivery order has a ceiling value of $5,068.32 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $240 firm fixed price delivery order contract to supply 120 tablets of 1 gram Colestipol HCL to the Defense Logistics Agency Troop Support Medical. To be performed in Conshohocken, Pennsylvania by October 13, 2023, this contract was awarded without a set-aside designation to fulfill the agency's requirements for the pharmaceutical product. As the prime contractor, Amerisourcebergen Drug Corp will...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKHKW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,557.54, is for the provision of Colestipol HCl 1 GM Tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contract awards and Indefinite Delivery Contracts demonstrate its critical role in providing essential medical commodities to various government agencies, including the military and veterans' healthcare systems.

Generated 6/9/25, 9:57 AM